Filter
147
Text search:
johnson&Johnson
Featured
Recommendations
14
New Publications
23
Language
Document type
No document type
50
Studies & Reports
31
Guidelines
28
Fact sheets
17
Manuals
6
Situation Updates
5
Strategic & Response Plan
5
Resource Platforms
2
Infographics
2
Videos
1
Countries / Regions
Brazil
6
Africa
5
Congo, Democratic Republic of
4
Global
4
Germany
3
South Africa
3
Ghana
2
India
2
Kenya
2
Malawi
2
Ukraine
2
Colombia
2
Russia
2
Guinea
1
Liberia
1
Nigeria
1
Senegal
1
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Ethiopia
1
Uganda
1
Zambia
1
Chad
1
Bangladesh
1
Mozambique
1
Ecuador
1
Angola
1
South–East Asia Region
1
Latin America and the Carribbean
1
Western and Central Europe
1
Asia
1
Authors & Publishers
Publication Years
Category
Countries
39
Clinical Guidelines
13
Women & Child Health
7
Key Resources
5
Public Health
4
Pharmacy & Technologies
3
Capacity Building
1
Toolboxes
COVID-19
53
HIV
11
Mental Health
11
Ebola & Marburg
9
NTDs
8
TB
6
AMR
6
Caregiver
5
Rapid Response
4
Refugee
4
Global Health Education
4
Planetary Health
2
Health Financing Toolbox
2
2.0 Rapid Response
2
Disability
1
Conflict
1
Zika
1
Pharmacy
1
Available in different languages
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l
...
15 January 2021
Available in different languages
While virtually unheard of in developed countries, NTDs are a group of medically diverse parasitic and bacterial infectious diseases common in tropical and subtropical areas. NTDs affect more than 1.5 billion people annually, causing death, blindness, disfigurement, chronic pain, cognitive impairmen
...
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Orientations provisoires 19 juillet 2021
Compendium of Case Studies
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer
...
